Related references
Note: Only part of the references are listed.mTORC1 Phosphorylation Sites Encode Their Sensitivity to Starvation and Rapamycin
Seong A. Kang et al.
SCIENCE (2013)
Therapeutic Targeting of the Cyclin D3:CDK4/6 Complex in T Cell Leukemia
Catherine M. Sawai et al.
CANCER CELL (2012)
Temporal Changes in PTEN and mTORC2 Regulation of Hematopoietic Stem Cell Self-Renewal and Leukemia Suppression
Jeffrey A. Magee et al.
CELL STEM CELL (2012)
mTOR Complex 1 Plays Critical Roles in Hematopoiesis and Pten-Loss-Evoked Leukemogenesis
Demetrios Kalaitzidis et al.
CELL STEM CELL (2012)
mTORC1 is essential for leukemia propagation but not stem cell self-renewal
Takayuki Hoshii et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Subnuclear cyclin D3 compartments and the coordinated regulation of proliferation and immunoglobulin variable gene repression
Sarah E. Powers et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Vital roles of mTOR complex 2 in Notch-driven thymocyte differentiation and leukemia
Keunwook Lee et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
The genetic basis of early T-cell precursor acute lymphoblastic leukaemia
Jinghui Zhang et al.
NATURE (2012)
The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2
Greg M. Delgoffe et al.
NATURE IMMUNOLOGY (2011)
Targeting protein prenylation for cancer therapy
Norbert Berndt et al.
NATURE REVIEWS CANCER (2011)
mTORC1-Mediated Cell Proliferation, But Not Cell Growth, Controlled by the 4E-BPs
Ryan J. O. Dowling et al.
SCIENCE (2010)
High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemia
Alejandro Gutierrez et al.
BLOOD (2009)
Mammalian target of rapamycin inhibitors and their potential role in therapy in leukaemia and other haematological malignancies
David T. Teachey et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
A Requirement for Cyclin-Dependent Kinase 6 in Thymocyte Development and Tumorigenesis
Miaofen G. Hu et al.
CANCER RESEARCH (2009)
Targeting mTOR with rapamycin One dose does not fit all
David A. Foster et al.
CELL CYCLE (2009)
Oncogenic Kras Initiates Leukemia in Hematopoietic Stem Cells
Amit J. Sabnis et al.
PLOS BIOLOGY (2009)
Exploiting the mammalian target of rapamycin pathway in hematologic malignancies
Jessica K. Altman et al.
CURRENT OPINION IN HEMATOLOGY (2008)
Multi-genetic events collaboratively contribute to Pten-null leukaemia stem-cell formation
Wei Guo et al.
NATURE (2008)
K-RasG12D expression induces hyperproliferation and aberrant signaling in primary hematopoietic stem/progenitor cells
Margaret E. M. Van Meter et al.
BLOOD (2007)
Faithful activation of an extra-bright red fluorescent protein in knock-in Cre-reporter mice ideally suited for lineage tracing studies
Herve Luche et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
Essential role for cyclin D3 in granulocyte colony-stimulating factor-driven expansion of neutrophil granulocytes
Ewa Sicinska et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance
Guo Wei et al.
CANCER CELL (2006)
Cyclin D3 is down-regulated by rapamycin in HER-2-overexpressing breast cancer cells
Pilar Garcia-Morales et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells
Omer H. Yilmaz et al.
NATURE (2006)
PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention
Jiwang Zhang et al.
NATURE (2006)
Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB
DD Sarbassov et al.
MOLECULAR CELL (2006)
Phosphorylation and functional inactivation of TSC2 by Erk: Implications for tuberous sclerosis and cancer pathogenesis
Li Ma et al.
CELL (2006)
Phosphorylation and functional inactivation of TSC2 by Erk: Implications for tuberous sclerosis and cancer pathogenesis
L Ma et al.
CELL (2005)
Polycomb group gene mel-18 regulates early T progenitor expansion by maintaining the expression of Hes-1, a target of the notch pathway
M Miyazaki et al.
JOURNAL OF IMMUNOLOGY (2005)
Conditional expression of oncogenic K-ras from its endogenous promoter induces a myeloproliferative disease
IT Chan et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Somatic activation of oncogenic Kras in hematopoietic cells initiates a rapidly fatal myeloproliferative disorder
BS Braun et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Evidence for cyclin D3 as a novel target of rapamycin in human T lymphocytes
M Hleb et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Requirement for cyclin D3 in lymphocyte development and T cell leukemias
E Sicinska et al.
CANCER CELL (2003)
Share Paper
